Dow Up0.08% Nasdaq Down0.30%

Esperion Therapeutics, Inc. (ESPR)

-NasdaqGM
16.34 Up 0.12(0.74%) Sep 19, 4:00PM EDT
|After Hours : 16.34 0.00 (0.00%) Sep 19, 4:40PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development6,528  5,400  7,339  3,483  
Selling General and Administrative2,726  2,490  2,397  1,924  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,254) (7,890) (9,736) (5,407)
Income from Continuing Operations
Total Other Income/Expenses Net17  16  47  169  
Earnings Before Interest And Taxes(9,237)(7,874)(9,689)(5,238)
Interest Expense1   -   -  1  
Income Before Tax(9,238)(7,874)(9,689)(5,239)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(9,238)(7,874)(9,689)(5,239)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (9,238) (7,874) (9,689) (5,239)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (9,238) (7,874) (9,689) (5,239)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.